Clinical Trial Data Sharing: Compliance Guide

Clinical trial data sharing means moving patient-level records, lab results, adverse event reports, and case report forms between sponsors, CROs, sites, and regulators while meeting HIPAA, GDPR Article 9, ICH E6(R3) GCP, and 21 CFR Part 11. The files involved — pseudonymized CSV exports of CRF data, SDTM/ADaM datasets in .xpt, scanned consent forms as .pdf, and DICOM imaging — need end-to-end encryption, verifiable audit trails, and retention controls that survive a regulatory inspection years after the trial closes.

What Makes Trial Data Harder Than Regular PHI

A trial dataset isn't just protected health information. It's a regulated product that the FDA, EMA, or PMDA may audit a decade later. A Phase III oncology study might produce 800 GB of source documents, 120 GB of medical imaging per site, and a locked database that has to reconcile against every transfer log. Lose the transfer history for a single adverse event file, and you're looking at a Form 483 observation or a data integrity finding under EMA's Reflection Paper on expectations for electronic source data.

That's why the 250 MB attachment limit on Outlook or the public-link approach of Dropbox doesn't cut it. You need cryptographic proof that file A left the site, arrived intact at the sponsor, and wasn't altered in transit.

Mapping Your Data to the Right Regulatory Framework

Before picking a transfer method, classify what you're actually moving:

• Source documents (CRFs, consent, SAE reports) fall under 21 CFR Part 11 for electronic records. Part 11.10(e) requires secure, computer-generated, time-stamped audit trails.
• Pseudonymized patient datasets are GDPR Article 4(5) pseudonymous data — still personal data, still needing a lawful basis under Article 6 and safeguards under Article 32.
• Anonymized publication data deposited in repositories like ClinicalStudyDataRequest.com or Vivli must meet the ICH E3 data-sharing guidance.
• EU data leaving the EEA triggers Chapter V transfer rules. Standard Contractual Clauses under the 2021 EU Commission Decision are the default mechanism.
• US clinical data under HIPAA needs a Business Associate Agreement with every vendor touching PHI, including your transfer platform.

Map each file type to its controlling regulation before you open the transfer tool. That mapping drives encryption choices and retention.

Encryption That Survives Regulatory Scrutiny

Regulators don't accept "we use SSL" anymore. They want specifics. HHS OCR guidance on HIPAA references NIST SP 800-111 for data-at-rest and NIST SP 800-52 Rev. 2 for data-in-transit. Practical floor:

• TLS 1.3 for the transfer channel (TLS 1.2 with AEAD ciphers is acceptable; SSLv3 and TLS 1.0/1.1 are not).
• AES-256-GCM for at-rest file encryption with authenticated encryption.
• PBKDF2-SHA256 with 600,000+ iterations or Argon2id for password-derived keys if you're using passphrases.
• Client-side encryption for the highest-risk files so the transfer provider never holds plaintext.

HexaTransfer runs AES-256-GCM in the browser before upload, which matches the zero-knowledge model regulators increasingly expect for cross-border trial data.

Audit Trail Requirements Under ICH E6(R3) and Part 11

Your transfer system has to produce an audit trail that an FDA inspector can reconstruct without calling your vendor's support line. The minimum fields:

1. User identity (authenticated, not just "site03@hospital.org")
2. File hash (SHA-256) at upload and at download
3. Timestamps in UTC with source time zone
4. IP address of sender and receiver
5. Success or failure status
6. Password or key exchange method

Under ICH E6(R3) Section 4.2.5, sponsors must maintain records of all data transfers for the duration of the trial plus the retention period — typically 25 years for marketing authorization dossiers under EU Regulation 536/2014 Article 58. If your vendor deletes logs after 90 days, you have a compliance gap.

Pseudonymization Before Files Leave the Site

GDPR Article 4(5) defines pseudonymization as processing so that data can no longer be attributed to a specific data subject without additional information kept separately. For trial transfers, that means the re-identification key stays at the investigator site, never in the same transfer as the coded dataset.

Practical workflow: the site ships SDTM datasets keyed by subject number (e.g., 1001-0042) while the linking table that maps subject numbers to names and MRNs stays in the site's EDC behind role-based access. If a laptop with the coded dataset gets stolen on a train, there's no direct identifier exposure — though EDPB Opinion 28/2024 still treats the coded data as personal.

Cross-Border Transfers and Schrems II Reality

A German site sending data to a US sponsor after Schrems II (CJEU Case C-311/18) needs more than SCCs. The EDPB Recommendations 01/2020 require a Transfer Impact Assessment documenting supplementary measures. Encryption where the provider genuinely can't decrypt is the cleanest supplementary measure on the EDPB's list.

For trials involving China, the Personal Information Protection Law (PIPL) Article 38 requires either a CAC security assessment, certification, or standard contract — and human genetic resources under the HGR Regulations add another layer. Russia's Federal Law 152-FZ demands localization. Don't assume one transfer workflow fits every site.

Chain of Custody From Site to Sponsor to Regulator

A defensible chain of custody means you can tell a regulator: "File SAE-0042-v3.pdf was generated at Site 04 on 2026-03-12 14:22 UTC with SHA-256 hash 8f3a...; transferred to Sponsor Medical Monitor on 2026-03-12 14:24 UTC with identical hash; acknowledged in the safety database at 14:31 UTC."

Build this chain into the transfer SOP, not as an afterthought. Tools like Medidata Rave, Veeva Vault CDMS, and Oracle Clinical One log source events, but the transfer layer between them and external collaborators is often where chain-of-custody breaks. A transfer service that writes the SHA-256 into the audit log and shows it to both sides closes that gap.

Handling Imaging and Large Datasets

Radiology reads for oncology trials, cardiology ECG tracings, and digital pathology whole-slide images push file sizes into the gigabytes. A typical whole-slide SVS file runs 2-4 GB; a DICOM study with MRI sequences can hit 500 MB. Email is out. FTP without TLS is out. SFTP works but lacks the user-facing audit dashboard auditors want.

Web-based transfer with resumable uploads, per-file encryption, and expiring links handles this range. Keep individual transfers under 10 GB so a failed upload doesn't cost hours of re-transmission, and split larger submissions into logical bundles (one visit, one subject, one read).

Retention, Destruction, and the Right to Be Forgotten

GDPR Article 17 gives participants a right to erasure, but Article 17(3)(c) carves out scientific research where erasure would impair research objectives. You still need a deletion policy for the transfer artifacts — the copies on the transfer server, not the trial master file.

Configure transfers to auto-expire after 7 or 14 days. The working copy disappears; the authoritative copy lives in your validated eTMF. Document this in your Data Management Plan so an EMA inspector sees intentional lifecycle management, not accidental leftovers in a file-sharing tool.

Making the Workflow Practical for Sites

Investigator sites juggle multiple sponsors, each with a different portal, each demanding a fresh login. That's how files end up on personal Gmail. Keep it simple: one transfer workflow per sponsor, clear instructions in the site initiation binder, and a passphrase channel separate from the transfer channel (SMS for the link, phone call for the password works).

For ad-hoc transfers — a late-arriving consent scan, an unexpected imaging request — a no-account encrypted transfer service removes friction. Try it at hexatransfer.com — free, no account, 10 GB max. Then log the transfer in your site file the same way you'd log a courier shipment: date, time, recipient, file description, confirmation number.

Clinical trial data sharing isn't one problem. It's pseudonymization, encryption, audit, cross-border law, and retention stitched together. Get the stitching right and inspections become paperwork reviews instead of crises.